CBMG and GE Healthcare China establish joint tech lab

Published: 11-Apr-2017
Research & Development Pharmaceutical Cell & Gene Therapy

Research and development collaboration to take place in Cellular Biomedicine GMP facilities

Clinical-stage biopharmaceutical firm, Cellular Biomedicine (CBMG), has established a research collaboration with GE Healthcare Life Sciences China to develop industrial control processes in Chimeric Antigen Receptor T-cell (CAR-T) and stem cell manufacturing.

A joint laboratory within CBMG’s new Shanghai Zhangjiang GMP-facility will be established and dedicated to the development of a functionally integrated and automated immunotherapy cell preparation system.

The two companies plan to develop automated CAR-T and stem cell manufacturing capabilities that build upon the accreditation of CBMG’s GMP facilities in Shanghai, Wuxi and Beijing.

Cellular Biomedicine's GMP facilities in China consist of twelve independent cell production lines, designed and managed according to both China and US GMP standards.

CBMG's new Zhangjiang facility and Beijing GMP-facilities will have a combined 70,000 square feet for development and production.

  • Companies:
  • Cellular Biomedicine Group CBMG
  • GE Group
See more

You may also like

Manufacturing

Chime Biologics announces $190m funds to accelerate capacity expansion

Read more
The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 years

Trending Articles

  1. The three musketeers of pharmaceutical quality control GMP, GAMP5, and 21CFR11 explained
  2. APIs: Bioreactor hoists with a multipurpose twist Peter Devenny of PalPharma describes the solution for a biotech facility in Switzerland designed to handle filled bioreactors across GMP areas to produce ten metric tons of antibody per year
  3. Thermo Fisher Scientific opens sterile drug facility in Asia The global company has built a new manufacturing facility and expanded capabilities in Singapore to enable the country’s science and technology sector to accelerate research, development and manufacturing of critical medicines and vaccines
  4. Microbiological monitoring: Adapting to new rapid methods regulatory demands Dr Wan Li Low from Cherwell takes a look at the shift towards Rapid Microbiology Methods (RMM) and their validation
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    The importance of growth promotion testing Given the critical nature of microbiological quality tests which are employed to ensure that pharmaceutical products are safe for human use, it is in turn essential to undertake quality control (QC) tests to ensure that the culture media being used for these is fit for purpose and performs properly. Cherwell Laboratories' Steven Brimble explains

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Chime Biologics announces $190m funds to accelerate capacity expansion

The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 years
Design & Build

GE Healthcare and Germfree working on modular bioprocessing solution

The project is a rapidly deployable process-ready cleanroom and bioprocessing platforms for biotherapeutics such as gene therapy
Design & Build

Bayer chooses Fluor and GE Healthcare for new cell culture technology centre

Company will invest US$150 million in new California facility expected to be ready for clinical production in late 2021
Manufacturing

GE Healthcare and Rockwell collaborate on next-gen bioprocessing automation

Companies will combine automation, IT and single-use solution expertise to streamline workflows resulting in faster times to market
Finance

GE agrees to sell BioPharma unit to Danaher for US$21.4 billion

The business behind KuBio manufacturing-in-a-box will be a standalone company within Danaher's Life Sciences segment
Design & Build

GE Healthcare and G-CON Manufacturing team up

The two US companies have agreed to work together for the improvement of cell therapy and viral vector manufacturing
Pharmaceutical

Janssen, Merck and GE Healthcare join forces in the UK

Pharma companies are industrial partners of Britain's first facility dedicated to innovation in vaccines manufacturing
Subscribe now